Opdivo (Nivolumab)

Opdivo (nivolumab) WholeSaler, Supplier


Opdivo (nivolumab) is a cancer medicine that works with your immune system to interfere with the growth and spread of cancer cells in the body. This monoclonal antibody blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2.

Indication and Usage: 

  • Metastatic melanoma-patients with BRAF V600 mutation-positive unresectable 
  • Metastatic Non-Small Cell Lung Cancer 
  • Classical Hodgkin Lymphoma
  • Squamous Cell Carcinoma Of The Head And Neck

Side Effects:

Common side effects of Opdivo includes:

  • atigue.
  • rash.
  • itching.
  • cough.
  • upper respiratory tract infection.
  • swelling of the extremities.
  • shortness of breath.
  • muscle pain.

Dosage form & Strength:

  • Opdivo (nivolumab) 240mg/24ml injection
  • Opdivo (nivolumab) 100mg/10ml injection 
  • Opdivo (nivolumab) 40mg/4ml injection 

Rasso Swiss Pharma is a wholesaler, distributor, supplier for Opdivo (nivolumab).